208 related articles for article (PubMed ID: 33237434)
1. Exploratory study of selected nucleotide variants in GRIN1, GRIN2A and GRIN2B encoding subunits of the NMDA receptor in a targeted group of schizophrenia patients with chronic cognitive impairment.
Krzystanek M; Asman M; Witecka J; Pałasz A; Wiaderkiewicz R
Pharmacol Rep; 2021 Feb; 73(1):269-277. PubMed ID: 33237434
[TBL] [Abstract][Full Text] [Related]
2. Selected single-nucleotide variants in GRIN1, GRIN2A, and GRIN2B encoding subunits of the NMDA receptor are not biomarkers of schizophrenia resistant to clozapine: exploratory study.
Krzystanek M; Asman M; Witecka J; Pałasz A; Wiaderkiewicz R
Pharmacol Rep; 2021 Feb; 73(1):309-315. PubMed ID: 33025395
[TBL] [Abstract][Full Text] [Related]
3. Association of GRIN1 and GRIN2A-D with schizophrenia and genetic interaction with maternal herpes simplex virus-2 infection affecting disease risk.
Demontis D; Nyegaard M; Buttenschøn HN; Hedemand A; Pedersen CB; Grove J; Flint TJ; Nordentoft M; Werge T; Hougaard DM; Sørensen KM; Yolken RH; Mors O; Børglum AD; Mortensen PB
Am J Med Genet B Neuropsychiatr Genet; 2011 Dec; 156B(8):913-22. PubMed ID: 21919190
[TBL] [Abstract][Full Text] [Related]
4. An association study of the N-methyl-D-aspartate receptor NR1 subunit gene (GRIN1) and NR2B subunit gene (GRIN2B) in schizophrenia with universal DNA microarray.
Qin S; Zhao X; Pan Y; Liu J; Feng G; Fu J; Bao J; Zhang Z; He L
Eur J Hum Genet; 2005 Jul; 13(7):807-14. PubMed ID: 15841096
[TBL] [Abstract][Full Text] [Related]
5. Significant association between the genetic variations in the 5' end of the N-methyl-D-aspartate receptor subunit gene GRIN1 and schizophrenia.
Zhao X; Li H; Shi Y; Tang R; Chen W; Liu J; Feng G; Shi J; Yan L; Liu H; He L
Biol Psychiatry; 2006 Apr; 59(8):747-53. PubMed ID: 16476413
[TBL] [Abstract][Full Text] [Related]
6. Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia.
Tarabeux J; Kebir O; Gauthier J; Hamdan FF; Xiong L; Piton A; Spiegelman D; Henrion É; Millet B; ; Fathalli F; Joober R; Rapoport JL; DeLisi LE; Fombonne É; Mottron L; Forget-Dubois N; Boivin M; Michaud JL; Drapeau P; Lafrenière RG; Rouleau GA; Krebs MO
Transl Psychiatry; 2011 Nov; 1(11):e55. PubMed ID: 22833210
[TBL] [Abstract][Full Text] [Related]
7. A recently-discovered NMDA receptor gene, GRIN3B, is associated with duration mismatch negativity.
Lin YT; Hsieh MH; Liu CC; Hwang TJ; Chien YL; Hwu HG; Liu CM
Psychiatry Res; 2014 Aug; 218(3):356-8. PubMed ID: 24814139
[TBL] [Abstract][Full Text] [Related]
8. Association analysis of the genetic variants of the N-methyl D-aspartate receptor subunit 2b (NR2b) and treatment-refractory schizophrenia in the Chinese.
Chiu HJ; Wang YC; Liou YJ; Lai IC; Chen JY
Neuropsychobiology; 2003; 47(4):178-81. PubMed ID: 12824739
[TBL] [Abstract][Full Text] [Related]
9. In-silico investigation of coding variants potentially affecting the functioning of the glutamatergic N-methyl-D-aspartate receptor in schizophrenia.
Tsavou A; Curtis D
Psychiatr Genet; 2019 Apr; 29(2):44-50. PubMed ID: 30664045
[TBL] [Abstract][Full Text] [Related]
10. A microsatellite repeat in the promoter of the N-methyl-D-aspartate receptor 2A subunit (GRIN2A) gene suppresses transcriptional activity and correlates with chronic outcome in schizophrenia.
Itokawa M; Yamada K; Yoshitsugu K; Toyota T; Suga T; Ohba H; Watanabe A; Hattori E; Shimizu H; Kumakura T; Ebihara M; Meerabux JM; Toru M; Yoshikawa T
Pharmacogenetics; 2003 May; 13(5):271-8. PubMed ID: 12724619
[TBL] [Abstract][Full Text] [Related]
11. Association between polymorphisms in the GRIN1 gene 5' regulatory region and schizophrenia in a northern Han Chinese population and haplotype effects on protein expression in vitro.
Liu YP; Ding M; Zhang XC; Liu Y; Xuan JF; Xing JX; Xia X; Yao J; Wang BJ
BMC Med Genet; 2019 Jan; 20(1):26. PubMed ID: 30704411
[TBL] [Abstract][Full Text] [Related]
12. Study of Early Onset Schizophrenia: Associations of
Poltavskaya EG; Fedorenko OY; Kornetova EG; Loonen AJM; Kornetov AN; Bokhan NA; Ivanova SA
Life (Basel); 2021 Sep; 11(10):. PubMed ID: 34685369
[TBL] [Abstract][Full Text] [Related]
13. Disease-associated GRIN protein truncating variants trigger NMDA receptor loss-of-function.
Santos-Gómez A; Miguez-Cabello F; García-Recio A; Locubiche-Serra S; García-Díaz R; Soto-Insuga V; Guerrero-López R; Juliá-Palacios N; Ciruela F; García-Cazorla À; Soto D; Olivella M; Altafaj X
Hum Mol Genet; 2021 Feb; 29(24):3859-3871. PubMed ID: 33043365
[TBL] [Abstract][Full Text] [Related]
14. GRIN2B gain of function mutations are sensitive to radiprodil, a negative allosteric modulator of GluN2B-containing NMDA receptors.
Mullier B; Wolff C; Sands ZA; Ghisdal P; Muglia P; Kaminski RM; André VM
Neuropharmacology; 2017 Sep; 123():322-331. PubMed ID: 28533163
[TBL] [Abstract][Full Text] [Related]
15. Distinct roles of
Myers SJ; Yuan H; Kang JQ; Tan FCK; Traynelis SF; Low CM
F1000Res; 2019; 8():. PubMed ID: 31807283
[TBL] [Abstract][Full Text] [Related]
16. Genetic variants of the NMDA receptor influence cortical excitability and plasticity in humans.
Mori F; Ribolsi M; Kusayanagi H; Siracusano A; Mantovani V; Marasco E; Bernardi G; Centonze D
J Neurophysiol; 2011 Oct; 106(4):1637-43. PubMed ID: 21753020
[TBL] [Abstract][Full Text] [Related]
17. Modification of cognitive performance in schizophrenia by complexin 2 gene polymorphisms.
Begemann M; Grube S; Papiol S; Malzahn D; Krampe H; Ribbe K; Friedrichs H; Radyushkin KA; El-Kordi A; Benseler F; Hannke K; Sperling S; Schwerdtfeger D; Thanhäuser I; Gerchen MF; Ghorbani M; Gutwinski S; Hilmes C; Leppert R; Ronnenberg A; Sowislo J; Stawicki S; Stödtke M; Szuszies C; Reim K; Riggert J; Eckstein F; Falkai P; Bickeböller H; Nave KA; Brose N; Ehrenreich H
Arch Gen Psychiatry; 2010 Sep; 67(9):879-88. PubMed ID: 20819981
[TBL] [Abstract][Full Text] [Related]
18. Association analysis for NMDA receptor subunit 2B (GRIN2B) genetic variants and psychopathology and clozapine response in schizophrenia.
Hong CJ; Yu YW; Lin CH; Cheng CY; Tsai SJ
Psychiatr Genet; 2001 Dec; 11(4):219-22. PubMed ID: 11807413
[TBL] [Abstract][Full Text] [Related]
19. Changes in subunit composition of NMDA receptors in animal models of schizophrenia by repeated administration of methamphetamine.
Oka M; Ito K; Koga M; Kusumi I
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Dec; 103():109984. PubMed ID: 32473191
[TBL] [Abstract][Full Text] [Related]
20. [A role of interactions between N-methyl-D-aspartate and dopamine receptors in facial emotion recognition impairment in schizophrenia].
Alfimova MV; Golimbet VE; Korovaitseva GI; Lezheiko TV; Tikhonov DV; Ganisheva TK; Berezin NB; Snegireva AA; Shemiakina TK
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(6):47-52. PubMed ID: 28745671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
